Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 4
1989 4
1990 9
1991 11
1992 8
1993 6
1994 3
1995 2
1996 4
1997 2
1998 5
1999 9
2000 11
2001 10
2002 21
2003 16
2004 14
2005 12
2006 5
2007 14
2008 3
2009 10
2010 9
2011 7
2012 14
2013 15
2014 5
2015 5
2016 7
2017 7
2018 4
2019 5
2020 5
2021 5
2022 2
2023 1
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Results by year

Filters applied: . Clear all
Page 1
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL.
Rousselot P, Coudé MM, Gokbuget N, Gambacorti Passerini C, Hayette S, Cayuela JM, Huguet F, Leguay T, Chevallier P, Salanoubat C, Bonmati C, Alexis M, Hunault M, Glaisner S, Agape P, Berthou C, Jourdan E, Fernandes J, Sutton L, Banos A, Reman O, Lioure B, Thomas X, Ifrah N, Lafage-Pochitaloff M, Bornand A, Morisset L, Robin V, Pfeifer H, Delannoy A, Ribera J, Bassan R, Delord M, Hoelzer D, Dombret H, Ottmann OG; European Working Group on Adult ALL (EWALL) group. Rousselot P, et al. Among authors: ottmann og. Blood. 2016 Aug 11;128(6):774-82. doi: 10.1182/blood-2016-02-700153. Epub 2016 Apr 27. Blood. 2016. PMID: 27121472 Free PMC article.
Polo-like kinases in AML.
Berg T, Bug G, Ottmann OG, Strebhardt K. Berg T, et al. Among authors: ottmann og. Expert Opin Investig Drugs. 2012 Aug;21(8):1069-74. doi: 10.1517/13543784.2012.691163. Epub 2012 Jun 6. Expert Opin Investig Drugs. 2012. PMID: 22667760
Asciminib for Ph+ ALL: a step forward?
Lang F, Ottmann OG. Lang F, et al. Among authors: ottmann og. Blood. 2025 Feb 6;145(6):551-552. doi: 10.1182/blood.2024027064. Blood. 2025. PMID: 39913337 No abstract available.
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes.
Brunner AM, Esteve J, Porkka K, Knapper S, Traer E, Scholl S, Garcia-Manero G, Vey N, Wermke M, Janssen JJWM, Narayan R, Fleming S, Loo S, Tovar N, Kontro M, Ottmann OG, Naidu P, Sun H, Han M, White R, Zhang N, Mohammed A, Sabatos-Peyton CA, Steensma DP, Rinne ML, Borate UM, Wei AH. Brunner AM, et al. Among authors: ottmann og. Am J Hematol. 2024 Feb;99(2):E32-E36. doi: 10.1002/ajh.27161. Epub 2023 Nov 22. Am J Hematol. 2024. PMID: 37994196 Free article. Clinical Trial.
Final analysis of the GMALL-PH-01 trial: phase II study of standard chemotherapy in combination with dasatinib in first line treatment of Philadelphia chromosome positive acute lymphoblastic leukemia.
Lang F, Voss A, Kobbe G, Junghanss C, Beck J, Viardot A, Wendelin K, Panse J, Heberling L, Vucinic V, Böll B, Topp M, Hoelzer D, Serve H, Goekbuget N, Ottmann OG, Pfeifer H. Lang F, et al. Among authors: ottmann og. Leuk Lymphoma. 2025 Jun;66(6):1079-1087. doi: 10.1080/10428194.2025.2460737. Epub 2025 Feb 8. Leuk Lymphoma. 2025. PMID: 39921529 Free article. Clinical Trial.
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.
Brüggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, Asnafi V, Baruchel A, Bassan R, Benoit Y, Biondi A, Cavé H, Dombret H, Fielding AK, Foà R, Gökbuget N, Goldstone AH, Goulden N, Henze G, Hoelzer D, Janka-Schaub GE, Macintyre EA, Pieters R, Rambaldi A, Ribera JM, Schmiegelow K, Spinelli O, Stary J, von Stackelberg A, Kneba M, Schrappe M, van Dongen JJ; European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL); International Berlin-Frankfurt-Münster Study Group (I-BFM-SG). Brüggemann M, et al. Among authors: ottmann og. Leukemia. 2010 Mar;24(3):521-35. doi: 10.1038/leu.2009.268. Epub 2009 Dec 24. Leukemia. 2010. PMID: 20033054 Review.
Activation of signaling pathways in models of t(6;9)-acute myeloid leukemia.
Chiriches C, Khan D, Wieske M, Guillen N, Rokicki M, Guy C, Wilson M, Heesom KJ, Ottmann OG, Ruthardt M. Chiriches C, et al. Among authors: ottmann og. Ann Hematol. 2022 Oct;101(10):2179-2193. doi: 10.1007/s00277-022-04905-9. Epub 2022 Aug 8. Ann Hematol. 2022. PMID: 35941390 Free PMC article.
Defective megakaryocytic development in myelodysplastic syndromes.
Hofmann WK, Kalina U, Koschmieder S, Seipelt G, Hoelzer D, Ottmann OG. Hofmann WK, et al. Among authors: ottmann og. Leuk Lymphoma. 2000 Jun;38(1-2):13-9. doi: 10.3109/10428190009060315. Leuk Lymphoma. 2000. PMID: 10811444 Review.
Clinical effects of recombinant human interleukin-3.
Ganser A, Lindemann A, Seipelt G, Ottmann OG, Herrmann F, Eder M, Frisch J, Schulz G, Mertelsmann R, Hoelzer D. Ganser A, et al. Among authors: ottmann og. Am J Clin Oncol. 1991;14 Suppl 1:S51-63. doi: 10.1097/00000421-199112001-00010. Am J Clin Oncol. 1991. PMID: 2048566 Review.
248 results